Antisense And RNAi Therapeutics Market Size, Share & Trends Report

Antisense And RNAi Therapeutics Market (2025 - 2030) Size, Share & Trends Analysis Report By Technology (RNA Interference, Antisense RNA), By Application (Ocular, Genetic), By Route of Administration (Intrathecal, Intravenous), By Region, And Segment Forecasts

Market Segmentation

Antisense & RNAi Therapeutics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- RNA Interference
- Antisense RNA
Antisense & RNAi Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Ocular
- Cardiometabolic & Renal Disorders
- Cancer
- Respiratory Disorders
- Skin Diseases
- Neurodegenerative Disorders
- Genetic Disorders
- Infectious Diseases
Antisense & RNAi Therapeutics Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Intravenous Injections
- Intrathecal Injections
- Subcutaneous Injections
- Other Delivery Methods
Antisense & RNAi Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
    - Antisense RNA
  - North America Antisense & RNAi Therapeutics Market, by Application
    - Ocular
    - Cardio metabolic & Renal Disorders
    - Respiratory Disorders
    - Skin Diseases
    - Cancer
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
  - North America Antisense & RNAi Therapeutics Market, by Route of Administration
    - Intravenous Injections
    - Intrathecal Injections
    - Subcutaneous Injections
    - Other Delivery Methods
  - U.S.
    - U.S. Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - U.S. Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - U.S. Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Canada
    - Canada Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Canada Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Canada Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
- Europe
  - Europe Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
    - Antisense RNA
  - Europe Antisense & RNAi Therapeutics Market, by Application
    - Ocular
    - Cardio metabolic & Renal Disorders
    - Respiratory Disorders
    - Skin Diseases
    - Cancer
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
  - Europe Antisense & RNAi Therapeutics Market, by Route of Administration
    - Intravenous Injections
    - Intrathecal Injections
    - Subcutaneous Injections
    - Other Delivery Methods
  - Germany
    - Germany Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Germany Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Germany Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - UK
    - UK Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - UK Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - UK Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - France
    - France Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - France Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - France Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Italy
    - Italy Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Italy Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Italy Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Spain
    - Spain Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Spain Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Spain Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Sweden
    - Sweden Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Sweden Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Sweden Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Denmark
    - Denmark Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Denmark Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Denmark Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Norway
    - Norway Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Norway Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Norway Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
- Asia Pacific
  - Asia Pacific Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
    - Antisense RNA
  - Asia Pacific Antisense & RNAi Therapeutics Market, by Application
    - Ocular
    - Cardio metabolic & Renal Disorders
    - Respiratory Disorders
    - Cancer
    - Skin Diseases
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
  - Asia Pacific Antisense & RNAi Therapeutics Market, by Route of Administration
    - Intravenous Injections
    - Intrathecal Injections
    - Subcutaneous Injections
    - Other Delivery Methods
  - China
    - China Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - China Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Cancer
      - Genetic Disorders
      - Infectious Diseases
    - China Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Japan
    - Japan Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Japan Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Japan Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - India
    - India Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - India Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - India Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - South Korea
    - South Korea Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - South Korea Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Cancer
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - South Korea Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Australia
    - Australia Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Australia Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Cancer
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Australia Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Thailand
    - Thailand Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Thailand Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Cancer
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Thailand Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
- Latin America
  - Latin America Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
    - Antisense RNA
  - Latin America Antisense & RNAi Therapeutics Market, by Application
    - Ocular
    - Cardiometabolic & Renal Disorders
    - Cancer
    - Respiratory Disorders
    - Skin Diseases
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
  - Latin America Antisense & RNAi Therapeutics Market, by Route of Administration
    - Intravenous Injections
    - Intrathecal Injections
    - Subcutaneous Injections
    - Other Delivery Methods
  - Brazil
    - Brazil Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Brazil Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Cancer
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Brazil Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Mexico
    - Mexico Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Mexico Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Mexico Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Argentina
    - Argentina Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Argentina Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Argentina Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
- MEA
  - MEA Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
    - Antisense RNA
  - MEA Antisense & RNAi Therapeutics Market, by Application
    - Ocular
    - Cardiometabolic & Renal Disorders
    - Respiratory Disorders
    - Skin Diseases
    - Cancer
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
  - MEA Antisense & RNAi Therapeutics Market, by Route of Administration
    - Intravenous Injections
    - Intrathecal Injections
    - Subcutaneous Injections
    - Other Delivery Methods
  - South Africa
    - South Africa Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - South Africa Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - South Africa Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Saudi Arabia
    - Saudi Arabia Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Saudi Arabia Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Saudi Arabia Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - UAE
    - UAE Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - UAE Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cancer
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - UAE Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments